Around 80% of CRC cases have adenomatous polyposis coli (APC) mutation, a tumour suppressor gene, leading to the accumulation of nuclear β‐catenin and increased expression of target genes associated with proliferation and invasion [34]. The gene discussed is APC; the disease is colorectal carcinoma.